LOGICMARK INC (LGMK) Fundamental Analysis & Valuation

NASDAQ:LGMK • US67091J6029

0.0115 USD
0 (-5.74%)
At close: May 30, 2025
0.0063 USD
-0.01 (-45.22%)
After Hours: 5/30/2025, 8:11:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LGMK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

LGMK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While LGMK has a great health rating, there are worries on its profitability. LGMK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. LGMK Profitability Analysis

1.1 Basic Checks

  • In the past year LGMK has reported negative net income.
  • LGMK had a negative operating cash flow in the past year.
  • In the past 5 years LGMK always reported negative net income.
  • LGMK had a negative operating cash flow in each of the past 5 years.
LGMK Yearly Net Income VS EBIT VS OCF VS FCFLGMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • LGMK has a Return On Assets of -38.67%. This is in the lower half of the industry: LGMK underperforms 63.83% of its industry peers.
  • LGMK has a Return On Equity (-42.37%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -38.67%
ROE -42.37%
ROIC N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
LGMK Yearly ROA, ROE, ROICLGMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • LGMK's Gross Margin of 65.71% is fine compared to the rest of the industry. LGMK outperforms 69.15% of its industry peers.
  • In the last couple of years the Gross Margin of LGMK has declined.
  • The Profit Margin and Operating Margin are not available for LGMK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
LGMK Yearly Profit, Operating, Gross MarginsLGMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. LGMK Health Analysis

2.1 Basic Checks

  • LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LGMK has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LGMK has more shares outstanding
  • There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGMK Yearly Shares OutstandingLGMK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
LGMK Yearly Total Debt VS Total AssetsLGMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • LGMK has an Altman-Z score of -4.38. This is a bad value and indicates that LGMK is not financially healthy and even has some risk of bankruptcy.
  • LGMK has a Altman-Z score of -4.38. This is in the lower half of the industry: LGMK underperforms 69.68% of its industry peers.
  • There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.38
ROIC/WACCN/A
WACC9.05%
LGMK Yearly LT Debt VS Equity VS FCFLGMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • LGMK has a Current Ratio of 7.56. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LGMK (7.56) is better than 87.77% of its industry peers.
  • LGMK has a Quick Ratio of 7.25. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 7.25, LGMK belongs to the best of the industry, outperforming 88.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.56
Quick Ratio 7.25
LGMK Yearly Current Assets VS Current LiabilitesLGMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. LGMK Growth Analysis

3.1 Past

  • LGMK shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.31%.
  • Looking at the last year, LGMK shows a small growth in Revenue. The Revenue has grown by 1.56% in the last year.
  • The Revenue for LGMK have been decreasing by -10.39% on average. This is quite bad
EPS 1Y (TTM)-4.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.44%
Revenue 1Y (TTM)1.56%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-0.73%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGMK Yearly Revenue VS EstimatesLGMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LGMK Yearly EPS VS EstimatesLGMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2023 2024 2025 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

0

4. LGMK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LGMK. In the last year negative earnings were reported.
  • Also next year LGMK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGMK Price Earnings VS Forward Price EarningsLGMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGMK Per share dataLGMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LGMK Dividend Analysis

5.1 Amount

  • LGMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

LGMK Fundamentals: All Metrics, Ratios and Statistics

LOGICMARK INC

NASDAQ:LGMK (5/30/2025, 8:11:29 PM)

After market: 0.0063 -0.01 (-45.22%)

0.0115

0 (-5.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15
Earnings (Next)08-11
Inst Owners2.62%
Inst Owner Change-99.76%
Ins Owners0.03%
Ins Owner Change2.32%
Market Cap6.63M
Revenue(TTM)9.88M
Net Income(TTM)-9.75M
Analysts43.33
Price Target0.26 (2160.87%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DP-3.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-649%
Min EPS beat(2)-1005.85%
Max EPS beat(2)-292.16%
EPS beat(4)2
Avg EPS beat(4)-307.89%
Min EPS beat(4)-1005.85%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-3.25%
Max Revenue beat(2)-1.22%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-100%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-42.43
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS0.04
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.67%
ROE -42.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.71%
FCFM N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.56
Quick Ratio 7.25
Altman-Z -4.38
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)13.92%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.44%
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.56%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-0.73%
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.88%
OCF growth 3YN/A
OCF growth 5YN/A

LOGICMARK INC / LGMK FAQ

What is the fundamental rating for LGMK stock?

ChartMill assigns a fundamental rating of 2 / 10 to LGMK.


What is the valuation status of LOGICMARK INC (LGMK) stock?

ChartMill assigns a valuation rating of 0 / 10 to LOGICMARK INC (LGMK). This can be considered as Overvalued.


What is the profitability of LGMK stock?

LOGICMARK INC (LGMK) has a profitability rating of 1 / 10.


Can you provide the financial health for LGMK stock?

The financial health rating of LOGICMARK INC (LGMK) is 7 / 10.


Can you provide the dividend sustainability for LGMK stock?

The dividend rating of LOGICMARK INC (LGMK) is 0 / 10 and the dividend payout ratio is -3.08%.